<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24532" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Lupus Miliaris Disseminatus Faciei</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Slater</surname>
            <given-names>Nathaniel</given-names>
          </name>
          <aff>University of Texas Health Science Center at Houston</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sathe</surname>
            <given-names>Nishad C.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rapini</surname>
            <given-names>Ronald P.</given-names>
          </name>
          <aff>University of Texas McGovern Medical School at Houston</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nathaniel Slater declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nishad Sathe declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ronald Rapini declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>1</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24532.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Lupus miliaris disseminatus faciei (LMDF) is an idiopathic granulomatous disease predominantly affecting facial skin. This unique dermatosis, often challenging to diagnose and manage, shares features with other granulomatous disorders, such as rosacea and sarcoidosis. Despite being uncommon and of unclear etiology, LMDF's clinical presentation and histopathological characteristics set it apart, posing complexities in treatment.</p>
        <p>This activity covers the intricacies of LMDF, providing insights into its etiology, pathophysiology, and management. Learners can expect an in-depth exploration of LMDF, starting with its elusive etiology and immune-mediated mechanisms proposed in current literature. Clinical presentations, specifically symmetrical red-to-yellow-to-brown papules on the central face with potential eyelid involvement, are thoroughly discussed. Histopathological findings, including caseous necrosis within granulomas, will aid in distinguishing LMDF from other facial granulomatous disorders.&#x000a0;Various treatment courses, their efficacy, and potential challenges are explored to equip learners with a comprehensive understanding.</p>
        <p>A key focus of this course is recognizing the integral role of the interprofessional team in evaluating and treating patients with LMDF. Dermatologists, pathologists, rheumatologists, and other healthcare professionals are crucial in the comprehensive care of individuals with this condition. This collaborative learning experience aims to prepare healthcare professionals for effective teamwork in addressing the challenges LMDF poses.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the characteristic clinical features of lupus miliaris disseminatus faciei for prompt and accurate diagnosis.</p></list-item><list-item><p>Evaluate the severity and progression of lupus miliaris disseminatus faciei through standardized assessment tools, guiding appropriate treatment adjustments.</p></list-item><list-item><p>Develop the differential diagnosis and features that distinguish lupus miliaris disseminatus faciei from other facial granulomatous disorders.</p></list-item><list-item><p>Facilitate seamless care coordination among healthcare professionals managing lupus miliaris disseminatus faciei, ensuring a cohesive and patient-centered approach.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24532&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24532">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24532.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Lupus miliaris disseminatus faciei (LMDF) is primarily an idiopathic granulomatous disease affecting facial skin, particularly the eyelids.<xref ref-type="bibr" rid="article-24532.r1">[1]</xref><xref ref-type="bibr" rid="article-24532.r2">[2]</xref>&#x000a0;Nosologically, this condition is on a spectrum of facial granulomatous dermatoses and shares overlapping features with rosacea and sarcoidosis; however, a differentiating feature is the presence of caseous necrosis (separating it from sarcoidosis) and the lack of photoaggravation and erythema (separating it from rosacea).<xref ref-type="bibr" rid="article-24532.r3">[3]</xref>&#x000a0;In most cases, this disorder resolves spontaneously within several years but can leave potentially disfiguring scarring.</p>
        <p>The diagnosis was reportedly first noted in 1878 by Fox and colleagues.<xref ref-type="bibr" rid="article-24532.r4">[4]</xref>&#x000a0;The name derives from a historical association with tuberculosis based on its clinical and histopathologic appearance of granulomas. More recent authors have proposed adopting the term facial idiopathic granulomas with regressive evolution instead of the entrenched LMDF. However, a name change has not appeared to be widely accepted.<xref ref-type="bibr" rid="article-24532.r5">[5]</xref>&#x000a0;Older terms for a similar facial granulomatous dermatosis include micropapular tuberculid, Lewandowsky eruption, and lupoid rosacea.<xref ref-type="bibr" rid="article-24532.r6">[6]</xref>&#x000a0;Acne agminata has been used to refer to similar lesions in the axilla. However, most authors consider LMDF a unique entity separate from other diagnoses.</p>
      </sec>
      <sec id="article-24532.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of LMDF is uncertain, and there are around 200 cases reported in the literature.<xref ref-type="bibr" rid="article-24532.r4">[4]</xref>&#x000a0;The earliest reports presumed that lesions of LMDF were related to tuberculosis based on similar clinicopathologic findings to other tuberculids. The term&#x000a0;<italic toggle="yes">tuberculid</italic>&#x000a0;was historically used for reactive conditions associated with tuberculosis, in which the infectious agent is present elsewhere and is not found in the skin lesions. However, LMDF does not arise in association with pulmonary tuberculosis and does not generally respond to anti-tuberculous medications, though they have been reportedly used in some cases. Tuberculin skin testing is often negative in these patients.<xref ref-type="bibr" rid="article-24532.r7">[7]</xref>&#x000a0;Moreover, investigations, including histochemical staining for mycobacteria and tissue cultures and polymerase chain reaction-based studies, have consistently failed to demonstrate evidence of&#x000a0;<italic toggle="yes">M. tuberculosis</italic>&#x000a0;organisms within the LMDF granulomas.<xref ref-type="bibr" rid="article-24532.r8">[8]</xref><xref ref-type="bibr" rid="article-24532.r9">[9]</xref>&#x000a0;A possible relationship with an unknown non-tuberculous mycobacterium has not been completely excluded.<xref ref-type="bibr" rid="article-24532.r8">[8]</xref>&#x000a0;Other organisms, such as&#x000a0;<italic toggle="yes">Cutibacterium acnes</italic>&#x000a0;and&#x000a0;<italic toggle="yes">Demodex</italic>&#x000a0;species, have been thought to play a role, as they do have a role in the related diseases acne vulgaris and rosacea, although these connections are not entirely elucidated.<xref ref-type="bibr" rid="article-24532.r4">[4]</xref></p>
        <p>Similar to other facial granulomatous eruptions, it is often postulated that initial immune-mediated damage to the hair follicle leads to its subsequent rupture and provokes an allergic or foreign body granulomatous response to keratin, sebum, or microbial components in the dermis.<xref ref-type="bibr" rid="article-24532.r10">[10]</xref>&#x000a0;This hypothesis is supported by observations that the granulomatous infiltrate is often centered around a follicular structure, which can sometimes be seen on serial histologic sectioning if not initially evident.<xref ref-type="bibr" rid="article-24532.r5">[5]</xref>&#x000a0;Whether altered antigenicity of the hair follicle or sebaceous gland structures with subsequent T-cell mediated destruction or other disruption of the pilosebaceous unit is the inciting event is unknown. A relationship with hormonal effects on the pilosebaceous unit, as seen in certain acneiform variants, has not been shown.<xref ref-type="bibr" rid="article-24532.r5">[5]</xref></p>
      </sec>
      <sec id="article-24532.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>LMDF is uncommon, although precise incidence rates are unknown (approximately 200 cases have been reported).<xref ref-type="bibr" rid="article-24532.r4">[4]</xref>&#x000a0;LMDF can be seen across a wide range of ages, with the most common occurrence in young adults (the average age in one series was 33 years) and is rare in older adults, although there are cases of young children and older adults with the condition.<xref ref-type="bibr" rid="article-24532.r9">[9]</xref>&#x000a0;A clear gender predilection has not been established. However, in a retrospective review, the average age of women (43 years) was older than men (23 years), and all patients beyond their mid-30s were women; the lack of gender specificity is also thought to separate this condition from rosacea, which does show a gender predominance.<xref ref-type="bibr" rid="article-24532.r4">[4]</xref><xref ref-type="bibr" rid="article-24532.r11">[11]</xref></p>
      </sec>
      <sec id="article-24532.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Some have considered LMDF as a variant of granulomatous rosacea, whereas other authors make the case for LMDF as a distinct entity.<xref ref-type="bibr" rid="article-24532.r12">[12]</xref>&#x000a0;The different clinical manifestations of rosacea are thought to result from the same underlying inflammatory pathways, including abnormalities of the innate immune system and neurovascular aberrations.<xref ref-type="bibr" rid="article-24532.r13">[13]</xref>&#x000a0;However, these vascular abnormalities are not seen in patients with LMDF.&#x000a0;<italic toggle="yes">Demodex folliculorum</italic>&#x000a0;mites are often found in skin biopsies from patients with rosacea. These mites may play an etiologic role, but they have not been consistently observed in skin biopsies from patients with LMDF.<xref ref-type="bibr" rid="article-24532.r5">[5]</xref><xref ref-type="bibr" rid="article-24532.r8">[8]</xref></p>
        <p>The biopsies of some patients with LMDF have shown a ruptured follicular infundibular cyst in the histologic sections.<xref ref-type="bibr" rid="article-24532.r8">[8]</xref>&#x000a0;Using a polymerase chain reaction assay, one study of 9 patients with LMDF demonstrated higher levels of&#x000a0;<italic toggle="yes">Cutibacterium acnes</italic>&#x000a0;bacteria within granulomatous areas separated by microdissection compared with normal-appearing skin regions. The authors suggested that the presence of&#x000a0;<italic toggle="yes">C. acnes</italic>&#x000a0;in the dermis around a disrupted hair follicle, in combination with host factors, may play a role in pathogenesis.<xref ref-type="bibr" rid="article-24532.r14">[14]</xref></p>
      </sec>
      <sec id="article-24532.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The histologic hallmark of LMDF is a granulomatous infiltrate, in some cases centered around hair follicle structures.<xref ref-type="bibr" rid="article-24532.r3">[3]</xref>&#x000a0;Both sarcoidal (non-caseating) and tuberculoid (with central caseation necrosis) granulomas have been observed (see&#x000a0;<bold>Images.</bold>&#x000a0;Granulomatous Inflammation Without Caseation and Caseating Granuloma), as have diffuse infiltrates of lymphocytes and histiocytes without well-formed granulomas.<xref ref-type="bibr" rid="article-24532.r15">[15]</xref>&#x000a0;The latter may be characteristic of early lesions and demonstrate a peri-adnexal pattern. Accompanying neutrophils with or without neutrophilic microabscesses have been variably observed, and some lymphocytic infiltrates may be observed.<xref ref-type="bibr" rid="article-24532.r4">[4]</xref>&#x000a0;Fibrosis is seen in late lesions, correlating with clinical scar formation.<xref ref-type="bibr" rid="article-24532.r4">[4]</xref>&#x000a0;Significant histologic overlap exists with granulomatous rosacea and other granulomatous disorders affecting the face.<xref ref-type="bibr" rid="article-24532.r5">[5]</xref></p>
      </sec>
      <sec id="article-24532.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients often present with a relatively abrupt onset of asymptomatic discrete red, yellow, brown, or skin-colored papules or nodules, which are occasionally pustular and symmetrically distributed predominantly on facial skin; these often predominate in the central face and are follicular or nonfollicular.<xref ref-type="bibr" rid="article-24532.r16">[16]</xref><xref ref-type="bibr" rid="article-24532.r4">[4]</xref>&#x000a0;The lower eyelids are most characteristically involved (see&#x000a0;<bold>Image.&#x000a0;</bold>Erythematous Papulonodules, Facial Eruption), and the forehead, cheeks, nose, upper lips, ears, chin, or neck involvement is common.<xref ref-type="bibr" rid="article-24532.r8">[8]</xref>&#x000a0;Extra-facial involvement is uncommon but has been reported in some cases, including on the trunk, extremities, and genital skin.<xref ref-type="bibr" rid="article-24532.r6">[6]</xref>&#x000a0;Co-morbidities have not generally been reported in association with LMDF.</p>
      </sec>
      <sec id="article-24532.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Symmetrically distributed inflammatory papules or papulopustules with histologically confirmed granulomatous inflammation on biopsy of the affected tissue should lead to consideration of the diagnosis. A background of erythema, telangiectasias, or a propensity for flushing would favor a diagnosis of granulomatous rosacea, as would exacerbation of disease by such triggers as steroid use, sunlight, alcohol, or spicy foods.<xref ref-type="bibr" rid="article-24532.r5">[5]</xref><xref ref-type="bibr" rid="article-24532.r9">[9]</xref>&#x000a0;Excluding an infectious etiology by histochemical stains (eg, Ziehl-Neelson stain) or tissue cultures is often prudent&#x02014;although the sensitivity of these tests is imperfect. Many authors have included serum calcium and angiotensin-converting enzyme levels in their workup, with or without chest x-ray and ophthalmologic exam, to help exclude sarcoidosis.<xref ref-type="bibr" rid="article-24532.r6">[6]</xref>&#x000a0;Serologic assays for tuberculosis and treponemal infection may also be considered.<xref ref-type="bibr" rid="article-24532.r8">[8]</xref></p>
      </sec>
      <sec id="article-24532.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Monitoring the disease without medical therapy could result in spontaneous resolution in 12 to 24 months; however, this will likely involve significant scarring.<xref ref-type="bibr" rid="article-24532.r4">[4]</xref>&#x000a0;The evidence for treatment of LMDF is limited to case series and retrospective reviews and should be considered even though the disease course is usually self-limited. This disease tends to be poorly responsive to topical or systemic therapies that are first-line for granulomatous rosacea. The efficacy of oral tetracyclines is poor, whereas the response to isotretinoin is mixed.<xref ref-type="bibr" rid="article-24532.r12">[12]</xref><xref ref-type="bibr" rid="article-24532.r15">[15]</xref><xref ref-type="bibr" rid="article-24532.r17">[17]</xref>&#x000a0;In one series, patients responded better to oral prednisolone (administered at starting doses of 10 mg daily) or oral dapsone (100 mg daily).<xref ref-type="bibr" rid="article-24532.r5">[5]</xref>&#x000a0;Combining these 2 agents seemed especially effective in patients who had failed monotherapy with either alone. In the same series, combining&#x000a0;oral dapsone with topical tacrolimus produced&#x000a0;an excellent response in 7 of 7 patients.<xref ref-type="bibr" rid="article-24532.r5">[5]</xref>&#x000a0;Results from other studies also report good responses to systemic corticosteroids.<xref ref-type="bibr" rid="article-24532.r18">[18]</xref>&#x000a0;Other treatments could include clofazimine, anti-tuberculous medications, carbon dioxide laser with chemical peel, or topical tacrolimus in combination with a 1450 nm or 1565 nm nonablative laser.<xref ref-type="bibr" rid="article-24532.r4">[4]</xref><xref ref-type="bibr" rid="article-24532.r19">[19]</xref><xref ref-type="bibr" rid="article-24532.r20">[20]</xref>&#x000a0;Early, effective treatment may reduce the risk of significant scarring.</p>
      </sec>
      <sec id="article-24532.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>As previously discussed, cutaneous tuberculosis or other infections, especially fungal, mycobacterial, treponemal, or leishmanial, should be considered. A bilateral, symmetric, relatively rapid onset in an otherwise well patient without associated symptoms makes an infectious etiology less likely. If an infection is excluded, the clinical and pathologic differential may include granulomatous rosacea at one end of the spectrum and cutaneous sarcoid at the other.</p>
        <p>Granulomatous variants of rosacea, like LMDF, can present with bilateral, symmetric facial papules with similar morphology. There is considerable histologic overlap, including a relationship to pilosebaceous units. However, LMDF may have larger granulomas that are more prone to caseation necrosis and are not expected to have actinic damage, vascular dilation, or the presence of&#x000a0;<italic toggle="yes">Demodex</italic>&#x000a0;mites.<xref ref-type="bibr" rid="article-24532.r9">[9]</xref>&#x000a0;The clinical features and course may help discriminate these entities. Notably, LMDF occurs without&#x000a0;phymatous changes, ocular involvement, or vascular manifestations of rosacea, such as background erythema, flushing, or telangiectasia.<xref ref-type="bibr" rid="article-24532.r4">[4]</xref>&#x000a0;Compared to rosacea, LMDF tends to affect adults at a younger age, including some cases in adolescents and exceptional cases in children; this may affect men more commonly, though other studies note there may not be a gender disparity in LMDF compared with rosacea.<xref ref-type="bibr" rid="article-24532.r4">[4]</xref><xref ref-type="bibr" rid="article-24532.r9">[9]</xref>&#x000a0;The involvement of eyelids, upper lips, and neck is more common in LMDF. Extra-facial involvement can also occur.<xref ref-type="bibr" rid="article-24532.r6">[6]</xref>&#x000a0;LMDF is more likely than rosacea to resolve spontaneously within several years but is more prone to significant pitted scarring. As discussed above, LMDF responds somewhat differently to treatment than rosacea, being less successfully treated with antibiotics and more successfully treated with corticosteroids.<xref ref-type="bibr" rid="article-24532.r5">[5]</xref><xref ref-type="bibr" rid="article-24532.r6">[6]</xref><xref ref-type="bibr" rid="article-24532.r8">[8]</xref></p>
        <p>Sarcoidosis should be excluded by clinical or laboratory investigations, especially in those whose disease is slow to regress or shows progression.<xref ref-type="bibr" rid="article-24532.r10">[10]</xref>&#x000a0;While LMDF has also been proposed as a possible forme fruste of sarcoid, it lacks clinical, laboratory, or radiographic evidence of extracutaneous manifestations and does not progress to visceral involvement. Histologically, the granulomatous infiltrate of LMDF is more prone to caseation and is often associated with pilosebaceous units.<xref ref-type="bibr" rid="article-24532.r6">[6]</xref>&#x000a0;Deep-seated, annular, or solitary lesions, or lesions involving the scalp or only a part of the face, should raise concern for the possibility of sarcoidosis.<xref ref-type="bibr" rid="article-24532.r10">[10]</xref></p>
        <p>Syringomas can also present on the eyelids and face, though these are sweat gland tumors and are thus histopathologically distinct from granulomatous facial dermatoses.&#x000a0;Other facial granulomatous disorders may also be considered in the differential, including granulomatous perioral dermatitis, facial Afro-Caribbean childhood eruption, and other deep fungal infections; caseous necrosis may lead away from these diagnoses.<xref ref-type="bibr" rid="article-24532.r4">[4]</xref><xref ref-type="bibr" rid="article-24532.r21">[21]</xref><xref ref-type="bibr" rid="article-24532.r22">[22]</xref></p>
      </sec>
      <sec id="article-24532.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>LMDF is a skin-limited disease. The natural history of the disease is typically spontaneous involution over months to several years, with a mean duration of 18 months in one series.<xref ref-type="bibr" rid="article-24532.r11">[11]</xref></p>
      </sec>
      <sec id="article-24532.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The primary long-term complication is facial scarring that can be significant and disfiguring. Early treatment may prevent or minimize considerable scarring.<xref ref-type="bibr" rid="article-24532.r5">[5]</xref></p>
      </sec>
      <sec id="article-24532.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Unlike rosacea, there are no documented lifestyle risk factors for LMDF. Once the diagnosis is made after the appropriate workup as described above, patients should be reassured about the skin-limited nature of the disease, the expected eventual resolution, and the potential for treatment to reduce the risk of permanent scarring.</p>
      </sec>
      <sec id="article-24532.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Patients with LMDF benefit from management&#x000a0;by an interprofessional team approach to improve outcomes. Primary care providers and dermatologists&#x000a0;should be involved. Specific treatment options, including dapsone and systemic corticosteroids, require careful education and monitoring, which should be reinforced by and coordinated with nursing and pharmacy professionals.&#x000a0;</p>
      </sec>
      <sec id="article-24532.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24532&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24532">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/lupus-miliaris-disseminatus-faciei/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24532">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24532/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24532">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-24532.s16">
        <fig id="article-24532.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Erythematous Papulonodules, Facial Eruption. Note eyelid involvement. Contributed by Ronald Rapini, MD.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Lupus__miliaris__Rosacea__3891154a" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-24532.s17">
        <fig id="article-24532.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Granulomatous Inflammation Without Caseation. There is a nodular collection of histiocytes with eosinophilic cytoplasm associated with lymphocytes. Contributed by Ronald Rapini, MD.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Lupus__miliaris__without__caseation-__DP89-2002" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-24532.s18">
        <fig id="article-24532.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Caseating Granuloma. Caseating granuloma is present in some cases of lupus miliaris disseminatus faciei. Contributed by Ronald Rapini, MD.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Lupus__miliaris__with__caseation-__DP95-3083__-unk1778" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-24532.s19">
        <title>References</title>
        <ref id="article-24532.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lenders</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lenders</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>J&#x000e4;ger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schaller</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Treatment of aseptic facial granuloma as a manifestation of pediatric rosacea with oral macrolides.</article-title>
            <source>Pediatr Dermatol</source>
            <year>2023</year>
            <season>Nov-Dec</season>
            <volume>40</volume>
            <issue>6</issue>
            <fpage>1064</fpage>
            <page-range>1064-1067</page-range>
            <pub-id pub-id-type="pmid">37667982</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gorham</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>SZ</given-names>
              </name>
            </person-group>
            <article-title>Response of Severe Lupus Miliaris Disseminatus Faciei to Treatment With Ruxolitinib Cream.</article-title>
            <source>JAMA Dermatol</source>
            <year>2023</year>
            <month>Jul</month>
            <day>01</day>
            <volume>159</volume>
            <issue>7</issue>
            <fpage>790</fpage>
            <page-range>790-791</page-range>
            <pub-id pub-id-type="pmid">37099285</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Almutairi</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Al-Sabah</surname>
                <given-names>HY</given-names>
              </name>
            </person-group>
            <article-title>Facial Granulomatous Rosacea: A Case Report.</article-title>
            <source>Cureus</source>
            <year>2023</year>
            <month>Sep</month>
            <volume>15</volume>
            <issue>9</issue>
            <fpage>e45391</fpage>
            <pub-id pub-id-type="pmid">37724096</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Toda-Brito</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Aranha</surname>
                <given-names>JMP</given-names>
              </name>
              <name>
                <surname>Tavares</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>Lupus miliaris disseminatus faciei.</article-title>
            <source>An Bras Dermatol</source>
            <year>2017</year>
            <season>Nov-Dec</season>
            <volume>92</volume>
            <issue>6</issue>
            <fpage>851</fpage>
            <page-range>851-853</page-range>
            <pub-id pub-id-type="pmid">29364447</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Mutairi</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Nosology and therapeutic options for lupus miliaris disseminatus faciei.</article-title>
            <source>J Dermatol</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>38</volume>
            <issue>9</issue>
            <fpage>864</fpage>
            <page-range>864-73</page-range>
            <pub-id pub-id-type="pmid">21714812</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van de Scheur</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>van der Waal</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Starink</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Lupus miliaris disseminatus faciei: a distinctive rosacea-like syndrome and not a granulomatous form of rosacea.</article-title>
            <source>Dermatology</source>
            <year>2003</year>
            <volume>206</volume>
            <issue>2</issue>
            <fpage>120</fpage>
            <page-range>120-3</page-range>
            <pub-id pub-id-type="pmid">12592078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barberio</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Delfino</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Lupus miliaris disseminatus faciei and its debated link to tuberculosis.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>97</fpage>
            <pub-id pub-id-type="pmid">12602984</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hodak</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Trattner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Feuerman</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Feinmesser</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsvieli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mitrani-Rosenbaum</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>David</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Lupus miliaris disseminatus faciei--the DNA of Mycobacterium tuberculosis is not detectable in active lesions by polymerase chain reaction.</article-title>
            <source>Br J Dermatol</source>
            <year>1997</year>
            <month>Oct</month>
            <volume>137</volume>
            <issue>4</issue>
            <fpage>614</fpage>
            <page-range>614-9</page-range>
            <pub-id pub-id-type="pmid">9390342</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chougule</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chatterjee</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yadav</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sethi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>De</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Saikia</surname>
                <given-names>UN</given-names>
              </name>
            </person-group>
            <article-title>Granulomatous Rosacea Versus Lupus Miliaris Disseminatus Faciei-2 Faces of Facial Granulomatous Disorder: A Clinicohistological and Molecular Study.</article-title>
            <source>Am J Dermatopathol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>40</volume>
            <issue>11</issue>
            <fpage>819</fpage>
            <page-range>819-823</page-range>
            <pub-id pub-id-type="pmid">30085956</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Makkar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ramesh</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>On the diagnosis of facial granulomatous dermatoses of obscure origin.</article-title>
            <source>Int J Dermatol</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>44</volume>
            <issue>7</issue>
            <fpage>606</fpage>
            <page-range>606-9</page-range>
            <pub-id pub-id-type="pmid">15985036</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Am&#x000ee;rudd&#x000ee;n</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mii</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fujimura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Katsuoka</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Clinical evaluation of 35 cases of lupus miliaris disseminatus faciei.</article-title>
            <source>J Dermatol</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>38</volume>
            <issue>6</issue>
            <fpage>618</fpage>
            <page-range>618-20</page-range>
            <pub-id pub-id-type="pmid">21352284</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berbis</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Privat</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Lupus miliaris disseminatus faciei: efficacy of isotretinoin.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1987</year>
            <month>Jun</month>
            <volume>16</volume>
            <issue>6</issue>
            <fpage>1271</fpage>
            <page-range>1271-2</page-range>
            <pub-id pub-id-type="pmid">3474247</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thiboutot</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cook-Bolden</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Draelos</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Gallo</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Granstein</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Macsai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gold</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>82</volume>
            <issue>6</issue>
            <fpage>1501</fpage>
            <page-range>1501-1510</page-range>
            <pub-id pub-id-type="pmid">32035944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishimoto</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Amano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Setoyama</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The detection of Propionibacterium acnes signatures in granulomas of lupus miliaris disseminatus faciei.</article-title>
            <source>J Dermatol</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>42</volume>
            <issue>4</issue>
            <fpage>418</fpage>
            <page-range>418-21</page-range>
            <pub-id pub-id-type="pmid">25616106</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rogel-Vence</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carmona-Rodr&#x000ed;guez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Herrera-Montoro</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Ruiz</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cortina-de la Calle</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez-Caminero</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Lupus miliaris disseminatus faciei with complete response to isotretinoin.</article-title>
            <source>Dermatol Online J</source>
            <year>2021</year>
            <month>Jan</month>
            <day>15</day>
            <volume>27</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">33560791</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>A case of lupus miliaris disseminatus faciei.</article-title>
            <source>Skin Health Dis</source>
            <year>2023</year>
            <month>Oct</month>
            <volume>3</volume>
            <issue>5</issue>
            <fpage>e285</fpage>
            <pub-id pub-id-type="pmid">37799365</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yadav</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sagar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Yadav</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Lupus Miliaris Disseminatus Faciei: Response to Combination of Isotretinoin and Oral Minipulse.</article-title>
            <source>Skinmed</source>
            <year>2022</year>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>307</fpage>
            <page-range>307-310</page-range>
            <pub-id pub-id-type="pmid">35976024</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dev</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Thami</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Longchar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sethuraman</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Lupus miliaris disseminatus faciei: a distinctive facial granulomatous eruption.</article-title>
            <source>BMJ Case Rep</source>
            <year>2017</year>
            <month>Jul</month>
            <day>14</day>
            <volume>2017</volume>
            <pub-id pub-id-type="pmid">28710244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jih</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Kimyai-Asadi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Hymes</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <article-title>Lupus miliaris disseminatus faciei: treatment with the 1450-nm diode laser.</article-title>
            <source>Arch Dermatol</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>141</volume>
            <issue>2</issue>
            <fpage>143</fpage>
            <page-range>143-5</page-range>
            <pub-id pub-id-type="pmid">15724009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maeng</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Son</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>YJ</given-names>
              </name>
            </person-group>
            <article-title>Pulsed-dye laser as an effective treatment for recalcitrant granulomatous rosacea and a potential regulator of CXCL9 expression.</article-title>
            <source>J Dermatol</source>
            <year>2024</year>
            <month>May</month>
            <volume>51</volume>
            <issue>5</issue>
            <fpage>722</fpage>
            <page-range>722-726</page-range>
            <pub-id pub-id-type="pmid">38009832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cribier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lieber-Mbomeyo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lipsker</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>[Clinical and histological study of a case of facial Afro-Caribbean childhood eruption (FACE)].</article-title>
            <source>Ann Dermatol Venereol</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>135</volume>
            <issue>10</issue>
            <fpage>663</fpage>
            <page-range>663-7</page-range>
            <pub-id pub-id-type="pmid">18929915</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24532.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khokhar</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Khachemoune</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A case of granulomatous rosacea: sorting granulomatous rosacea from other granulomatous diseases that affect the face.</article-title>
            <source>Dermatol Online J</source>
            <year>2004</year>
            <month>Jul</month>
            <day>15</day>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>6</fpage>
            <pub-id pub-id-type="pmid">15347488</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
